XML 20 R5.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Related Party
Nonrelated Party
Preferred Stock
Common Stock
Common Stock
Related Party
Common Stock
Nonrelated Party
Additional Paid-in Capital
Additional Paid-in Capital
Related Party
Additional Paid-in Capital
Nonrelated Party
Treasury Stock
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance, preferred (in shares) at Dec. 31, 2023         9,566                  
Beginning balance at Dec. 31, 2023 $ 222,489 $ 37     $ 9,273 $ 277     $ 472,834     $ 0 $ (259,895) $ 37
Beginning balance (in shares) at Dec. 31, 2023           276,733,329                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Warrant exercise (in shares)           31,534,861                
Warrant exercise 4,193         $ 31     4,162          
Issuance of stock for stock-based compensation/liabilities (in shares)             1,083,189 9,912,624            
Issuance of stock for stock-based compensation/liabilities     $ 2,500 $ 14,181     $ 1 $ 6   $ 2,499 $ 14,175      
Common stock issued (in shares)     1,083,189     67,368,125                
Common stock issued $ 189,214   $ 2,500     $ 68     189,146          
Tax withholdings related to net share settlements of stock-based compensation awards (in shares) (4,000,045)         (4,000,045)                
Tax withholdings related to net share settlements of stock-based compensation awards $ (16,761)               (16,761)          
Net loss (43,222)                       (43,222)  
Ending balance, preferred (in shares) at Sep. 30, 2024         9,566                  
Ending balance at Sep. 30, 2024 372,631       $ 9,273 $ 383     666,055     0 (303,080)  
Ending balance (in shares) at Sep. 30, 2024           382,632,083                
Beginning balance, preferred (in shares) at Jun. 30, 2024         9,566                  
Beginning balance at Jun. 30, 2024 386,241       $ 9,273 $ 374     656,941     0 (280,347)  
Beginning balance (in shares) at Jun. 30, 2024           374,456,722                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Warrant exercise (in shares)           2,292,200                
Warrant exercise 2,292         $ 2     2,290          
Issuance of stock for stock-based compensation/liabilities (in shares)               4,772,478            
Issuance of stock for stock-based compensation/liabilities       2,408       $ 3     2,405      
Common stock issued (in shares)           3,546,036                
Common stock issued $ 15,520         $ 4     15,516          
Tax withholdings related to net share settlements of stock-based compensation awards (in shares) (2,435,353)         (2,435,353)                
Tax withholdings related to net share settlements of stock-based compensation awards $ (11,097)               (11,097)          
Net loss (22,733)                       (22,733)  
Ending balance, preferred (in shares) at Sep. 30, 2024         9,566                  
Ending balance at Sep. 30, 2024 $ 372,631       $ 9,273 $ 383     666,055     0 (303,080)  
Ending balance (in shares) at Sep. 30, 2024           382,632,083                
Beginning balance, preferred (in shares) at Dec. 31, 2024 9,566       9,566                  
Beginning balance at Dec. 31, 2024 $ 244,445       $ 9,273 $ 404     685,261     (118,217) (332,276)  
Beginning balance (in shares) at Dec. 31, 2024 404,223,028         404,223,028                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Conversion of preferred stock to common stock (in shares)         (8)                  
Conversion of preferred stock to common stock         $ (8)                  
Conversion of preferred stock to common stock $ (12)               (4)          
Warrant exercise (in shares)           3,453,166                
Warrant exercise 3,129         $ 3     3,126          
Issuance of stock for stock-based compensation/liabilities (in shares)             798,319 9,942,826            
Issuance of stock for stock-based compensation/liabilities     $ 2,375 44,323     $ 1 $ 5   $ 2,374 44,318      
Common stock issued as consideration for business acquisition (in shares)           6,795,580                
Common stock issued as consideration for business acquisition 28,600         $ 7     28,593          
Common stock issued (in shares)     798,319     18,554,688                
Common stock issued 110,293   $ 2,400     $ 19     110,274          
2031 Convertible Notes conversion feature 511,191               511,191          
Purchase of capped call (100,600)               (100,600)          
Treasury stock repurchased $ (33,292)                     (33,292)    
Tax withholdings related to net share settlements of stock-based compensation awards (in shares) (4,553,363)         (4,553,363)                
Tax withholdings related to net share settlements of stock-based compensation awards $ (28,273)               (28,273)          
Net loss $ (534,838)                       (534,838)  
Ending balance, preferred (in shares) at Sep. 30, 2025 9,558       9,558                  
Ending balance at Sep. 30, 2025 $ 247,341       $ 9,265 $ 439     1,256,260     (151,509) (867,114)  
Ending balance (in shares) at Sep. 30, 2025 439,214,244         439,214,244                
Beginning balance, preferred (in shares) at Jun. 30, 2025         9,566                  
Beginning balance at Jun. 30, 2025 $ 174,332       $ 9,273 $ 415     728,217     (151,509) (412,064)  
Beginning balance (in shares) at Jun. 30, 2025           414,599,543                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Conversion of preferred stock to common stock (in shares)         (8)                  
Conversion of preferred stock to common stock         $ (8)                  
Conversion of preferred stock to common stock (12)               (4)          
Warrant exercise (in shares)           3,453,166                
Warrant exercise 3,129         $ 3     3,126          
Issuance of stock for stock-based compensation/liabilities (in shares)               1,806,667            
Issuance of stock for stock-based compensation/liabilities       $ 4,345             $ 4,345      
Common stock issued as consideration for business acquisition (in shares)           1,795,580                
Common stock issued as consideration for business acquisition 9,050         $ 2     9,048          
Common stock issued (in shares)           18,554,688                
Common stock issued 110,293         $ 19     110,274          
2031 Convertible Notes conversion feature 511,191               511,191          
Purchase of capped call (100,600)               (100,600)          
Treasury stock repurchased $ 0                          
Tax withholdings related to net share settlements of stock-based compensation awards (in shares) (995,400)         (995,400)                
Tax withholdings related to net share settlements of stock-based compensation awards $ (9,337)               (9,337)          
Net loss $ (455,050)                       (455,050)  
Ending balance, preferred (in shares) at Sep. 30, 2025 9,558       9,558                  
Ending balance at Sep. 30, 2025 $ 247,341       $ 9,265 $ 439     $ 1,256,260     $ (151,509) $ (867,114)  
Ending balance (in shares) at Sep. 30, 2025 439,214,244         439,214,244